{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:21:55Z","timestamp":1790234515852,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/onc.2016.500","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:15:33Z","timestamp":1491250533000},"page":"4336-4348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["TGF\u03b2 engages MEK\/ERK to differentially regulate benign and malignant pancreas cell function"],"prefix":"10.1038","volume":"36","author":[{"given":"D R","family":"Principe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Mangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"DeCant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-S","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H G","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J","family":"Grippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"BFonc2016500_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer j Clin 2014; 64: 9\u201329.","journal-title":"CA Cancer j Clin"},{"key":"BFonc2016500_CR2","doi-asserted-by":"publisher","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","volume":"106","author":"DR Principe","year":"2014","unstructured":"Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L et al. TGF-beta: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 2014; 106: djt369.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2016500_CR3","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1158\/0008-5472.CAN-15-1293","volume":"76","author":"DR Principe","year":"2016","unstructured":"Principe DR, DeCant B, Mascarinas E, Wayne EA, Diaz AM, Akagi N et al. TGFbeta signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis. Cancer Res 2016; 76: 2525\u20132539.","journal-title":"Cancer Res"},{"key":"BFonc2016500_CR4","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1038\/sj.onc.1206420","volume":"22","author":"FJ Nicolas","year":"2003","unstructured":"Nicolas FJ, Hill CS . Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. Oncogene 2003; 22: 3698\u20133711.","journal-title":"Oncogene"},{"key":"BFonc2016500_CR5","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-04-3995","volume":"65","author":"AL Gartel","year":"2005","unstructured":"Gartel AL, Radhakrishnan SK . Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005; 65: 3980\u20133985.","journal-title":"Cancer Res"},{"key":"BFonc2016500_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.96.3.1002","volume":"96","author":"J Brugarolas","year":"1999","unstructured":"Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T, Lees JA . Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc Natl Acad Sci USA 1999; 96: 1002\u20131007.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2016500_CR7","first-page":"93","volume":"14","author":"M Voss","year":"1999","unstructured":"Voss M, Wolff B, Savitskaia N, Ungefroren H, Deppert W, Schmiegel W et al. TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression. Int J Oncol 1999; 14: 93\u2013101.","journal-title":"Int J Oncol"},{"key":"BFonc2016500_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00006676-200105000-00002","volume":"22","author":"K Hashimoto","year":"2001","unstructured":"Hashimoto K, Nio Y, Sumi S, Toga T, Omori H, Itakura M et al. Correlation between TGF-beta1 and p21 (WAF1\/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas. Pancreas 2001; 22: 341\u2013347.","journal-title":"Pancreas"},{"key":"BFonc2016500_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/path.4440","volume":"235","author":"K Grabliauskaite","year":"2015","unstructured":"Grabliauskaite K, Hehl AB, Seleznik GM, Saponara E, Schlesinger K, Zuellig RA et al. p21(WAF1) (\/Cip1) limits senescence and acinar-to-ductal metaplasia formation during pancreatitis. J Pathol 2015; 235: 502\u2013514.","journal-title":"J Pathol"},{"key":"BFonc2016500_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10585-005-2891-x","volume":"22","author":"M Yasutome","year":"2005","unstructured":"Yasutome M, Gunn J, Korc M . Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis. Clin Exp Metastasis 2005; 22: 461\u2013473.","journal-title":"Clin Exp Metastasis"},{"key":"BFonc2016500_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.onc.1207222","volume":"23","author":"H Ijichi","year":"2004","unstructured":"Ijichi H, Otsuka M, Tateishi K, Ikenoue T, Kawakami T, Kanai F et al. Smad4-independent regulation of p21\/WAF1 by transforming growth factor-beta. Oncogene 2004; 23: 1043\u20131051.","journal-title":"Oncogene"},{"key":"BFonc2016500_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12943-015-0456-4","volume":"14","author":"J Bauer","year":"2015","unstructured":"Bauer J, Ozden O, Akagi N, Carroll T, Principe DR, Staudacher JJ et al. Activin and TGFbeta use diverging mitogenic signaling in advanced colon cancer. Mol Cancer 2015; 14: 182.","journal-title":"Mol Cancer"},{"key":"BFonc2016500_CR13","doi-asserted-by":"publisher","first-page":"e39381","DOI":"10.1371\/journal.pone.0039381","volume":"7","author":"J Bauer","year":"2012","unstructured":"Bauer J, Sporn JC, Cabral J, Gomez J, Jung B . Effects of activin and TGFbeta on p21 in colon cancer. PLoS One 2012; 7: e39381.","journal-title":"PLoS One"},{"key":"BFonc2016500_CR14","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","volume":"26","author":"MK Lee","year":"2007","unstructured":"Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J et al. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 2007; 26: 3957\u20133967.","journal-title":"EMBO J"},{"key":"BFonc2016500_CR15","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321: 1801\u20131806.","journal-title":"Science"},{"key":"BFonc2016500_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-12-4721","volume":"74","author":"JM Buonato","year":"2014","unstructured":"Buonato JM, Lazzara MJ . ERK1\/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. Cancer Res 2014; 74: 309\u2013319.","journal-title":"Cancer Res"},{"key":"BFonc2016500_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1593\/neo.04241","volume":"6","author":"L Xie","year":"2004","unstructured":"Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL . Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 2004; 6: 603\u2013610.","journal-title":"Neoplasia"},{"key":"BFonc2016500_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00109-011-0833-4","volume":"90","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Zeng R, Xu C, Liu L, Chen L, Kou P et al. Erbin inhibits TGF-beta1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway. J Mol Med 2012; 90: 563\u2013574.","journal-title":"J Mol Med"},{"key":"BFonc2016500_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10555-012-9396-2","volume":"32","author":"C Neuzillet","year":"2013","unstructured":"Neuzillet C, Hammel P, Tijeras-Raballand A, Couvelard A, Raymond E . Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Cancer Metastasis Rev 2013; 32: 147\u2013162.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2016500_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","volume":"277","author":"S Cagnol","year":"2010","unstructured":"Cagnol S, Chambard JC . ERK and cell death: mechanisms of ERK-induced cell death\u2014apoptosis, autophagy and senescence. FEBS J 2010; 277: 2\u201321.","journal-title":"FEBS J"},{"key":"BFonc2016500_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-4-41","volume":"4","author":"C Ciccarelli","year":"2005","unstructured":"Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P et al. p21WAF1 expression induced by MEK\/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer 2005; 4: 41.","journal-title":"Mol Cancer"},{"key":"BFonc2016500_CR22","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/emboj\/cdg189","volume":"22","author":"ML Coleman","year":"2003","unstructured":"Coleman ML, Marshall CJ, Olson MF . Ras promotes p21(Waf1\/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 2003; 22: 2036\u20132046.","journal-title":"EMBO J"},{"key":"BFonc2016500_CR23","doi-asserted-by":"publisher","first-page":"E1947","DOI":"10.1073\/pnas.1207607109","volume":"109","author":"A Warmflash","year":"2012","unstructured":"Warmflash A, Zhang Q, Sorre B, Vonica A, Siggia ED, Brivanlou AH . Dynamics of TGF-beta signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4. Proc Natl Acad Sci USA. 2012; 109: E1947\u2013E1956.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFonc2016500_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2013.07.010","volume":"339","author":"R Shen","year":"2013","unstructured":"Shen R, Wang Q, Cheng S, Liu T, Jiang H, Zhu J et al. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models. Cancer Lett 2013; 339: 135\u2013143.","journal-title":"Cancer Lett"},{"key":"BFonc2016500_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/gcc.20000","volume":"39","author":"H Fensterer","year":"2004","unstructured":"Fensterer H, Giehl K, Buchholz M, Ellenrieder V, Buck A, Kestler HA et al. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1. Genes Chromosomes Cancer 2004; 39: 224\u2013235.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc2016500_CR26","doi-asserted-by":"crossref","unstructured":"Principe DR, DeCant B, Staudacher J, Vitello D, Mangan RJ, Wayne EA et al. Loss of TGFbeta signaling promotes colon cancer progression and tumor-associated inflammation. Oncotarget 2016, e-pub ahead of print 4 June 2016.","DOI":"10.18632\/oncotarget.9830"},{"issue":"5","key":"BFonc2016500_CR27","doi-asserted-by":"publisher","first-page":"1680-1688.e7","DOI":"10.1053\/j.gastro.2009.01.066","volume":"136","author":"Patty Trobridge","year":"2009","unstructured":"Trobridge P, Knoblaugh S, Washington MK, Munoz NM, Tsuchiya KD, Rojas A et al. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology 2009; 136: 1680-8 e7.","journal-title":"Gastroenterology"},{"key":"BFonc2016500_CR28","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.1074\/jbc.M111598200","volume":"277","author":"D Tang","year":"2002","unstructured":"Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B et al. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002; 277: 12710\u201312717.","journal-title":"J Biol Chem"},{"key":"BFonc2016500_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","volume":"97","author":"S Torii","year":"2006","unstructured":"Torii S, Yamamoto T, Tsuchiya Y, Nishida E . ERK MAP kinase in G cell cycle progression and cancer. Cancer Sci 2006; 97: 697\u2013702.","journal-title":"Cancer Sci"},{"key":"BFonc2016500_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0006-2952(02)01135-8","volume":"64","author":"J Pouyssegur","year":"2002","unstructured":"Pouyssegur J, Volmat V, Lenormand P . Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol 2002; 64: 755\u2013763.","journal-title":"Biochem Pharmacol"},{"key":"BFonc2016500_CR31","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O, Kolch W . MAP kinase signalling pathways in cancer. Oncogene 2007; 26: 3279\u20133290.","journal-title":"Oncogene"},{"key":"BFonc2016500_CR32","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","volume":"26","author":"PJ Roberts","year":"2007","unstructured":"Roberts PJ, Der CJ . Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007; 26: 3291\u20133310.","journal-title":"Oncogene"},{"key":"BFonc2016500_CR33","first-page":"6999","volume":"48","author":"LC Schwarz","year":"1988","unstructured":"Schwarz LC, Gingras MC, Goldberg G, Greenberg AH, Wright JA . Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res 1988; 48: 6999\u20137003.","journal-title":"Cancer Res"},{"key":"BFonc2016500_CR34","first-page":"123","volume":"5","author":"J Filmus","year":"1993","unstructured":"Filmus J, Kerbel RS . Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol 1993; 5: 123\u2013129.","journal-title":"Curr Opin Oncol"},{"key":"BFonc2016500_CR35","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/carcin\/bgm159","volume":"28","author":"JY Chow","year":"2007","unstructured":"Chow JY, Quach KT, Cabrera BL, Cabral JA, Beck SE, Carethers JM . RAS\/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 2007; 28: 2321\u20132327.","journal-title":"Carcinogenesis"},{"key":"BFonc2016500_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE . Non-Smad pathways in TGF-beta signaling. Cell Res 2009; 19: 128\u2013139.","journal-title":"Cell Res"},{"key":"BFonc2016500_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1359-6101(99)00026-X","volume":"11","author":"KM Mulder","year":"2000","unstructured":"Mulder KM . Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 2000; 11: 23\u201335.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2016500_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/cr.2008.327","volume":"19","author":"KH Wrighton","year":"2009","unstructured":"Wrighton KH, Lin X, Feng XH . Phospho-control of TGF-beta superfamily signaling. Cell Res 2009; 19: 8\u201320.","journal-title":"Cell Res"},{"key":"BFonc2016500_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/01635581.2013.804580","volume":"65","author":"J Bachmann","year":"2013","unstructured":"Bachmann J, Buchler MW, Friess H, Martignoni ME . Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome. Nutr Cancer 2013; 65: 827\u2013833.","journal-title":"Nutr Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/onc2016500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/onc2016500","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2016.500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/onc2016500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:00:55Z","timestamp":1684472455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2016500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":39,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFonc2016500"],"URL":"https:\/\/doi.org\/10.1038\/onc.2016.500","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]},"assertion":[{"value":"19 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}